CLINICAL_TRIALS
trial_result
· 2014-08-08
Clinical Trial Update: Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial evaluating empagliflozin added to metformin in type 2 diabetes shows efficacy and safety; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2014-08-08